about
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokePlasmatic markers for early diagnostic and treatment decisions in ischemic strokeBiomarkers for strokeMicroelectrical sensors as emerging platforms for protein biomarker detection in point-of-care diagnostics.Misdiagnosis of stroke.A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsBiomarkers and acute brain injuries: interest and limitsNeuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.Anamnestic recall of stroke-related deficits: an animal model.Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.Biomarker panels in ischemic stroke.Correlation between Serum D-Dimer Level and Volume in Acute Ischemic StrokeMultiplexed protein measurement: technologies and applications of protein and antibody arrays.Blood biomarkers of ischemic stroke.Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarctionTiming of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.Blood transcriptome changes after stroke in an African American population.Candidate-based proteomics in the search for biomarkers of cardiovascular disease.CSF proteome: a protein repository for potential biomarker identification.The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarctionDetection of brain injury by fatty acid-binding proteins.A blood-based biomarker panel to risk-stratify mild traumatic brain injury.Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection.Multiple liquid chromatography separations and nanoESI-ion trap detection of plasma proteins in search of stroke biomarkers: A pilot study.Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review.Stroke-related translational research.Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attackA list of candidate cancer biomarkers for targeted proteomics.Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic strokeS100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage.Microarray methods for protein biomarker detectionMolecular biomarkers in stroke diagnosis and prognosis.Potential biomarkers for the diagnosis of stroke.Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.Invited article: searching for oracles? Blood biomarkers in acute stroke.CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine.Clinical application of blood biomarkers in cerebrovascular disease.
P2860
Q26766038-9A6D2E3D-EABA-428A-BD37-96C453AC321AQ26781099-5ADE5AC9-EF2B-4387-8FEA-539CD4BCB82AQ27004404-97942767-0728-411A-8EBC-6B380FEE9FF5Q30480197-36E006AA-D650-4F37-8690-310731925C7FQ31120792-B3CB7053-E7BC-4BB9-8662-38E8BCC2B927Q33474338-6A94B5CE-271E-4CBA-9048-CDEA12E03219Q33752053-86052915-37FF-4D01-AF67-A8E1205B4BBDQ34193737-6F1D1485-6A3E-4262-95B3-02FAB23B2AEAQ34473891-9709804D-22EE-475E-A96A-787BEC056C49Q34894419-D57F2573-D6B2-41E4-BBDE-D01942748426Q35112837-03772211-F2A0-4CD7-B727-D8189313B986Q35125900-0F9F1C40-4E11-4AFE-818A-F2AB90C6A407Q35503036-16B85D75-87BD-47A3-83C8-EDD4648A98D7Q35607467-98E2F914-D6A8-4483-A998-1130D7034260Q35648087-DB602C43-85EA-4D39-B491-2E8E53642981Q35688512-6649D940-D93A-4B17-875C-CF7C0F916965Q35749627-4EA3AD27-31C2-41EC-B067-B115C556C0CCQ35930251-29694D91-BEFE-448D-B8F1-B574D891A4F5Q35990040-13DADD7A-27B4-446D-98A6-00FD7063FB0BQ36168470-0D6FD536-B018-43AB-9024-47AD1D608686Q36182904-CD36256F-0400-4430-A2D1-F3F00FF3D60BQ36275438-0636A759-7EA8-4A76-BE1E-3B7DDE7C1B39Q36326665-44AE2787-BFB3-4C27-94E2-1FD2313D01FFQ36454485-1856DC3F-B328-4224-BE6F-5DFF712BAF7FQ36539414-55471DD8-D548-4F4D-BF2E-BC7D4A0EE217Q36571761-F20E0011-A5D0-4FAD-96E3-365CFE1E3D46Q36779120-29D5A07E-984B-4119-B4D9-645C50B87F99Q36953709-39D31808-45B4-437B-8499-BBC3800783A2Q37183514-4E86FFF2-36DF-4B13-904E-48CFD7E4C90CQ37212726-50D5776D-2ADD-4DC4-BE15-022AF3DEFB20Q37277962-3BC676AA-4EA0-43E8-8D5B-3A72E05580E8Q37280979-EC8F40A0-39BE-48A5-B9CF-C82332E1ECEEQ37318243-296CC63B-36E9-42BD-A454-CDE3340DBCA4Q37335033-3DF43AB8-1B5B-4D70-B2B7-599F3A2E13DCQ37408830-BFD203D5-6F31-48E8-A8C0-8A7AE300436EQ37451522-CCD8FCD6-4FD6-42D2-BEDB-924002CB88F5Q37568882-13C47B3B-DE1E-487D-9F50-03C17496BC33Q37571237-29BAADD9-8CB9-497A-A83A-A519B962F132Q37630537-073512E6-E643-40ED-AFDA-87333D238419Q37688066-BD8AEA06-C453-4636-BB8F-F74F9BBD99E1
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Early biomarkers of stroke.
@en
Early biomarkers of stroke.
@nl
type
label
Early biomarkers of stroke.
@en
Early biomarkers of stroke.
@nl
prefLabel
Early biomarkers of stroke.
@en
Early biomarkers of stroke.
@nl
P2093
P356
P1433
P1476
Early biomarkers of stroke.
@en
P2093
Daniel T Laskowitz
Gunars E Valkirs
Howard J Kirchick
Jeffrey R Dahlen
Joseph M Anderberg
Kenneth F Buechler
Kevin K Nakamura
Mark A Reynolds
Paul H McPherson
P304
P356
10.1373/49.10.1733
P407
P577
2003-10-01T00:00:00Z